According to Reuters, the consensus rating for Frontline (FRO) is 3.3, which means a “hold.”
Six analysts gave recommendations on Frontline. Of the analysts, 16.6% are bullish on the stock—one analyst gave a “buy” recommendation. Three analysts gave a “hold” recommendation, one gave a “sell” recommendation, and one gave a “strong sell” recommendation.
The consensus 12-month target price for Frontline is $5.02, which implies a potential upside of 3.7% from the market price on April 19.
According to Reuters’ consensus, Frontline’s revenue will be ~$87.7 million in 1Q18—compared to $178.5 million in 4Q17 and ~$121 million in 1Q17. Along with a fall in the revenue, the EBITDA (earnings before interest, taxes, and amortization) is estimated to be lower. Analysts expect Frontline’s 1Q18 EBITDA to be $34 million—compared to $60 million in 4Q17 and $97.3 million in 1Q17.
For 2018, analysts expect Frontline’s revenue to be $424 million—34% lower than its revenue of $646 million in 2017. Frontline’s 2018 EBITDA estimate stands at $182 million, which is lower than its EBITDA of $207 million in 2017.
Check out all the data we have added to our quote pages. Now you can get a valuation snapshot, earnings and revenue estimates, and historical data as well as dividend info. Take a look!
Next, we’ll discuss analysts’ recommendations and estimates for DHT Holdings.